Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/MIN-202> ?p ?o }
Showing triples 1 to 46 of
46
with 100 triples per page.
- MIN-202 abstract "MIN-202 (also known as JNJ-42847922, JNJ-922) is a selective, small-molecule antagonist of the OX2 receptor that is under development by Minerva Neurosciences and Johnson & Johnson's Janssen Pharmaceutica for the treatment of insomnia and major depressive disorder (MDD). As of December 2015, it is in phase II clinical trials for both insomnia and MDD. The chemical structure of MIN-202 has yet to be disclosed.".
- MIN-202 wikiPageExternalLink 800040115.
- MIN-202 wikiPageExternalLink minervaneurosciences.com.
- MIN-202 wikiPageExternalLink sleep-2015-abstract-supplement.pdf?sfvrsn=4.
- MIN-202 wikiPageExternalLink mediabstracts2015.pdf.
- MIN-202 wikiPageID "44927187".
- MIN-202 wikiPageLength "2796".
- MIN-202 wikiPageOutDegree "18".
- MIN-202 wikiPageRevisionID "695429548".
- MIN-202 wikiPageWikiLink Category:Antidepressants.
- MIN-202 wikiPageWikiLink Category:Hypnotics.
- MIN-202 wikiPageWikiLink Category:Orexin_antagonists.
- MIN-202 wikiPageWikiLink Chemical_structure.
- MIN-202 wikiPageWikiLink EMPA_(drug).
- MIN-202 wikiPageWikiLink Filorexant.
- MIN-202 wikiPageWikiLink Hypocretin_(orexin)_receptor_2.
- MIN-202 wikiPageWikiLink Insomnia.
- MIN-202 wikiPageWikiLink Janssen_Pharmaceutica.
- MIN-202 wikiPageWikiLink Johnson_&_Johnson.
- MIN-202 wikiPageWikiLink Lemborexant.
- MIN-202 wikiPageWikiLink Major_depressive_disorder.
- MIN-202 wikiPageWikiLink Minerva_Neurosciences.
- MIN-202 wikiPageWikiLink Phases_of_clinical_research.
- MIN-202 wikiPageWikiLink Receptor_antagonist.
- MIN-202 wikiPageWikiLink Small_molecule.
- MIN-202 wikiPageWikiLink Suvorexant.
- MIN-202 wikiPageWikiLink TCS-OX2-29.
- MIN-202 wikiPageWikiLinkText "MIN-202".
- MIN-202 wikiPageUsesTemplate Template:Citation_needed.
- MIN-202 wikiPageUsesTemplate Template:Insomnia_pharmacotherapies.
- MIN-202 wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- MIN-202 wikiPageUsesTemplate Template:Neuropeptidergics.
- MIN-202 wikiPageUsesTemplate Template:Reflist.
- MIN-202 subject Category:Antidepressants.
- MIN-202 subject Category:Hypnotics.
- MIN-202 subject Category:Orexin_antagonists.
- MIN-202 hypernym Antagonist.
- MIN-202 type Drug.
- MIN-202 comment "MIN-202 (also known as JNJ-42847922, JNJ-922) is a selective, small-molecule antagonist of the OX2 receptor that is under development by Minerva Neurosciences and Johnson & Johnson's Janssen Pharmaceutica for the treatment of insomnia and major depressive disorder (MDD). As of December 2015, it is in phase II clinical trials for both insomnia and MDD. The chemical structure of MIN-202 has yet to be disclosed.".
- MIN-202 label "MIN-202".
- MIN-202 sameAs Q19597962.
- MIN-202 sameAs m.012l6cnh.
- MIN-202 sameAs m.0138s04n.
- MIN-202 sameAs Q19597962.
- MIN-202 wasDerivedFrom MIN-202?oldid=695429548.
- MIN-202 isPrimaryTopicOf MIN-202.